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Table 1. Glomerular selectivity assessed by selectivity indexA more detailed experience with the measurement
vs. urinary IgG/transferrin ratio
of specific urinary marker proteins has recently been
N SI IgG/transferrinpublished [4].
SI#0.10 (HS) 15 0.0760.02 0.2460.11
SI$0.11#0.20 (MS) 34 0.1560.03 0.5060.25Axel Regeniter, Werner H. Siede, Andre´ Scholer,
SI$0.21 (NS) 40 0.3360.11 1.1761.19Peter Huber, Nikolaus Frischmuth, and Ju¨rg U. Steiger
Abbreviations are: HS, high selectivity; MS, moderate selectivity; NS, nonse-Basel, Switzerland, and Lemgo, Germany
lectivity; SI, selectivity index according to the formula of Cameron and Blandford
[2]; IgG/transferrin, ratio of IgG over transferrin measured in second morning
Correspondence to Axel Regeniter, M.D., Kantonsspital Basel, Uni- urine samples.
versity Hospital, Central Laboratory, Petersgraben 4, CH 4031 Basel,
Switzerland.
E-mail: regenitera@uhbs.ch
chronic renal failure, HS 0%, MS 25%, and NS 35%;REFERENCES
P 5 0.05. The selectivity index calculated as urinary IgG/1. Bazzi C, Petrini C, Rizza V, et al: A modern approach to selectivity
transferrin ratio does not show this type of association.of proteinuria and tubulointerstitial damage in nephrotic syndrome.
Kidney Int 58:1732–1741, 2000 Furthermore, our results in patients with focal segmental
2. Steinhauslin F, Wauters JP: Quantitation of proteinuria in kidney glomerulosclerosis and minimal change disease are simi-
transplant patients: Accuracy of the urinary protein/creatinine ratio.
lar to the results of Laurent et al [3], who found thatClin Nephrol 43:110–115, 1995
100% of patients with a selectivity index # 0.07 were3. Guder WG, Hofmann W: Differentiation of proteinuria and hema-
turia by single protein analysis in urine. Clin Biochem 26:277–282, steroid-responsive, while all patients with a selectivity
1993 index $ 0.17 were steroid-resistant. Finally, if, according
4. Regeniter A, Siede WH, Scholer A, et al: Interpreting complex
to the suggestion of Regeniter et al, urinary a2-macro-urinary patterns with MDI LABLINK: A statistical evaluation. Clin
globulin is measured, they are measuring three proteins,Chim Acta 297:261–273, 2000
while we are measuring four proteins (serum and urinary
IgG and transferrin). That is not a very big and “labori-
Reply from the authors ous” difference!
In conclusion, in our opinion, the selectivity index isThis letter from Regeniter et al about the best method
clinically useful in patients with nephrotic syndrome andto correctly assess the selectivity of proteinuria is rather
the correct method to assess the selectivity of proteinuriaconfusing. In one instance, they compare the selectivity
is by using the formula of Cameron and Blandford [2].index with the IgG/transferrin ratio, while in Table 1
Another method used to evaluate the characteristicsand another text mention the selectivity index is com-
of both the glomerular and tubular components of pro-pared with the transferrin/IgG ratio. Moreover, the au-
teinuria is to measure, in second morning urine samples,
thors do not specify whether the patients they studied
some proteins with different molecular weight [for exam-
had nephrotic proteinuria. The very high rates of unse- ple, IgG 150 kD and a1-microglobulin (a1m) 31.8 kD]lective proteinuria reported in Table 1, very different expressed in milligrams per gram of urinary creatinine
from the rates usually found in patients with nephrotic (UCr). In patients with membranous nephropathy (ab-
syndrome from primary glomerulonephritis, suggest that stract; Bazzi et al, J Am Soc Nephrol 9, 84A, 1998, up-
most patients tested had low levels of proteinuria. It is dated and submitted for publication) we found that the
well known that in this case the value of the selectivity patients with IgG excretion , vs $ 110 mg/g UCr have
index is not reliable. 100% and 20% remission (P 5 0.0001), respectively, and
In our study [1] we measured IgG and transferrin by the patients with a1m excretion , vs $ 33.5 mg/g UCr
immunonephelometry in second-morning urine samples have 0% vs. 58% progression to chronic renal failure
(Methods section) and calculated the selectivity index (P 5 0.0001), respectively.
according to the formula of Cameron and Blandford This is the most simple method to evaluate the quality
of proteinuria because only two urinary proteins are[2] in 89 patients with nephrotic syndrome. The simple
measured and their levels that, respectively, reflect thecalculation of the IgG/transferrin ratio in the same 89
alteration of size-selectivity and the impairment of tubu-patients shows values very different from that obtained
lar reabsorption of microproteins, have a high predictiveby the usual formula (Table 1). Moreover, our classifica-
value of functional outcome, at least in patients withtion of the selectivity index in patients with nephrotic
idiopathic membranous nephropathy.syndrome and baseline normal renal function fits very
well with the functional outcome: remission, high selec-
Claudio Bazzi, Concetta Petrini, Virginia Rizza,
tivity (HS) 100%; moderate selectivity (MS) 50%; and Girolamo Arrigo, and Giuseppe D’Amico
Milan, Italynonselectivity (NS) 29%; P 5 0.0001 and progression to
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To the Editor: Covic et al describe attempts to measure
“central arterial pressure waveforms” in hemodialysis
Reply from the authorpatients in Romania [1]. They claim their noninvasive
assessments of “aortic” blood pressure (BP) waveforms We thank Dr. Eldon Lehmann for his letter and the
using the SphygmoCor device (PWV Medical, Inc., Syd- interest he has shown in our recent publication [1].
ney, Australia) have been validated. However, they cite Over the last 2 years Dr. Lehmann, a noted expert in
no data to support this assertion. vascular imaging and methodology, with a long-standing
The authors write, “The software analytical program interest in arterial compliance, has repeatedly censured
also derived in real time from the measured radial artery other authors of other studies in which similar methods
waveform an aortic BP waveform using a validated trans- have been used [2–4].
fer function algorithm” [1, p 2636]. However, this is not Interested readers are urged to follow this correspon-
correct. The two references cited (23 and 24) have noth- dence trail across time, and several journals, the better
ing to do with the SphygmoCor and have not validated to appreciate the background to these comments.
the SphygmoCor’s generalized transfer function (GTF) The thrust of his comments to us can be summarized
algorithm. as follows. First, is there any justification/supportive evi-
Reference 23 is a 2-page short report from a 1992 dence for the use of a reverse generalized energy transfer
Supplement, a year before both the SphygmoCor radial
function (GTF), as opposed to an individualized energy
artery GTF was published [2], and the technique’s
transfer function? Second, which parameters can safelyUnited States Patent was granted [3]. Reference 24 did
be derived using a validated-GTF? Third, has there beennot use the SphygmoCor, but rather involved another
any independent validation of the use of such GTFs withGTF developed using a completely different computa-
noninvasively calibrated brachial artery blood pressure?tional technique. This approach has subsequently been
Finally, have the methodology and algorithms in use inshown to be ineffective in 67% of cases, when calibrated
the SphygmoCor device (PWV Medical, Inc., Sydney,noninvasively [4].
Australia) been validated? Our answers (for brevity)A search on Medline reveals a paucity of validation
are, “yes; aortic systolic blood pressure and augmen-work with the SphygmoCor reported in the literature.
tation index; yes, but not yet in the public domain; andFurthermore, no evidence has been provided to support
partly.” We have reason to hope that later this year thethe use of the device in patients with renal failure, let
answer to all of the questions will be “yes.” Until then,alone in those following hemodialysis. Given this, re-
we concede that complete validation of this extremelysearchers may wish to exercise caution in making claims
interesting and potentially useful pulse wave analysisabout the “validity” of the noninvasive approach, which,
technique is (eagerly) awaited.at present, remains completely unproven, especially in
renal disease.
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